Global Therapeutic Vaccines Market to Reach US$ 71.4 Billion by 2032, Spurred by Increasing Prevalence of Contagious Infections

September 07, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Therapeutic Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” the global therapeutic vaccines market size reached US$ 31.3 Billion in 2023. Therapeutic vaccines are immunotherapy designed to treat existing diseases. They work by stimulating or boosting the immune system of the body to recognize and fight specific pathogens or abnormal cells, such as cancer cells. They target diseases that a person already has as compared to preventive vaccines, which aim to protect individuals from contracting specific infectious diseases. They target and treat conditions caused by the virus, such as precancerous lesions.


Global Therapeutic Vaccines Market Trends:

The surging prevalence of contagious infections, such as human immunodeficiency virus (HIV), human papillomavirus (HPV), and acquired immune deficiency syndrome (AIDS), represents one of the major factors catalyzing the demand for therapeutic vaccines around the world. Moreover, the increasing number of airborne diseases due to the rising air pollution levels is augmenting the growth of the market. In addition, the growing number of clinical trials by pharmaceutical companies to improve therapeutic vaccines that offer long-lasting effects on immunization is influencing the market positively. Apart from this, continual technological advancements in the vaccine production process are strengthening the growth of the market. Looking forward, the market value is projected to reach US$ 71.4 Billion by 2032, expanding at a CAGR of 9.5% during 2024-2032.


Market Summary:

  • Based on the type, the market has been categorized into antigen vaccines, dendritic cell vaccine, DNA vaccine, and tumor cell vaccines. Presently, tumor cell vaccines hold the largest market share.
  • On the basis of the disease type, the market has been segregated into autoimmune disease, addiction, neurological disease, infectious disease, and other vaccines. Autoimmune disease vaccines currently account for the biggest share in the market.
  • Based on the technology, autologous vaccines dominate the market, followed by allogeneic vaccine.
  • On the basis of the distribution channel, the market has been divided into hospital, retail, and online pharmacies.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Amongst these, North America enjoys the leading position in the market.
  • The competitive landscape of the market has also been examined, with some of the key players being Agenus Inc., Argos Therapeutics Inc., Bavarian Nordic A/S, Cel-Sci Corporation, CSL Limited, Emergent Biosolutions Inc., GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A.


Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Type
  • Disease Type
  • Technology
  • Distribution Channel
  • Region
Types Covered Antigen Vaccines, Dendritic Cell Vaccine, DNA Vaccine, Tumor Cell Vaccines
Disease Types Covered Autoimmune Disease Vaccines, Addiction Vaccines, Neurological Disease Vaccine, Infectious Disease Vaccine, Others
Technologies Covered Autologous Vaccines, Allogeneic Vaccine
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agenus Inc., Argos Therapeutics Inc., Bavarian Nordic A/S, Cel-Sci Corporation, CSL Limited, Emergent Biosolutions Inc., GSK plc, Merck & Co. Inc., Pfizer Inc., Sanofi S.A. etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Therapeutic Vaccines Market to Reach US$ 71.4 Billion by 2032, Spurred by Increasing Prevalence of Contagious Infections
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More